Síndrome Postaguda de COVID-19

una cohorte de telemonitoreo de 12 meses para evaluar los síntomas persistentes y la calidad de vida

Autores/as

  • Raiany Franca Guimarães Universidade Federal do Espírito Santo image/svg+xml
  • Marcela Cangussu Barbalho Moulim Universidade Federal do Espírito Santo image/svg+xml
  • Veronica Lourenço Wittmer Pascoal Universidade Federal do Espírito Santo image/svg+xml
  • Lais Mello Serafim Universidade Federal do Espírito Santo image/svg+xml
  • Elizangela Kuster Universidade Federal do Espírito Santo image/svg+xml
  • Flavia Azevedo de Brito Hospital Universitário Cassiano Antônio Moraes
  • Vanessa Rodrigues Gomes Hospital Universitário Cassiano Antônio Moraes
  • Karla Nascimento Netto Zangerolame Hospital Universitário Cassiano Antônio Moraes
  • Jonaina Fiorim Pereira de Oliveira Hospital Universitário Cassiano Antônio Moraes
  • Juliana Zangirolami-Raimundo Centro Universitário FMABC
  • Rodrigo Daminello Raimundo Centro Universitário FMABC
  • Luiz Carlos Abreu Universidade Federal do Espírito Santo image/svg+xml
  • Flavia Marini Paro Universidade Federal do Espírito Santo image/svg+xml

DOI:

https://doi.org/10.47456/rbps.v27i1.47684

Palabras clave:

Síndrome postagudo de COVID-19, COVID-19, SARS-CoV-2, Calidad de vida, Telemonitoreo

Resumen

Introducción: Tras la pandemia de COVID-19, el síndrome postagudo de COVID-19 continúa representando un importante desafío para los sistemas de salud. Objetivo: Evaluar los síntomas respiratorios y la calidad de vida (CV) de pacientes previamente hospitalizados por COVID-19 doce meses después del alta, e identificar factores clínicos asociados. Métodos: Estudio longitudinal con una cohorte de 12 meses, realizado con adultos dados de alta tras hospitalización por COVID-19. Los participantes fueron evaluados mediante videollamadas o llamadas telefónicas y respondieron cuestionarios sobre síntomas persistentes y calidad de vida. Se utilizó la escala modificada del Medical Research Council (mMRC) para evaluar la disnea y el WHOQoL-BREF para medir la CV. Resultados: La cohorte incluyó 15 pacientes, con edad media de 63,53 ± 7,32 años. Doce meses después del alta, 66,66% presentaban al menos un síntoma persistente. La tos fue reportada por el 40% de los participantes, la fatiga por el 20%, la disnea en reposo por el 20% y la disnea durante las actividades por el 40%. El dominio físico presentó la menor puntuación de calidad de vida (9,14 ± 3,54). La edad, el sexo, la diabetes y un puntaje mMRC ≥ 1 se asociaron con la calidad de vida. Conclusión: La persistencia de síntomas respiratorios y el deterioro de la calidad de vida un año después del alta hospitalaria evidencian la necesidad de protocolos de rehabilitación intrahospitalaria y de programas de ejercicio físico y rehabilitación tras el alta.

Descargas

Los datos de descarga aún no están disponibles.

Referencias

Antoniou KM, Vasarmidi E, Russell AM, Andrejak C, Crestani B, Delcroix M, et al. European Respiratory Society statement on long COVID follow-up. Eur Respir J. 2022;60(2):2102174. doi: 10.1183/13993003.02174-2021.

Sisó-Almirall A, Brito-Zerón P, Conangla Ferrín L, Kostov B, Moragas Moreno A, Mestres J, et al. Long COVID-19: proposed primary care clinical guidelines for diagnosis and disease management. Int J Environ Res Public Health. 2021;18(8):4350. doi: 10.3390/ijerph18084350.

Abreu LC. Four years into the era of COVID-19: the virus persists and global vaccination efforts remain quiescent. J Hum Growth Dev. 2023;33(3):315-318. doi: 10.36311/jhgd.v33.15423.

Alkodaymi MS, Omrani OA, Ashraf N, Abou Shaar B, Almamlouk R, Riaz M, et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect. 2022;28(5):657-666. doi: 10.1016/j.cmi.2022.01.014.

Natarajan A, Shetty A, Delanerolle G, Zeng Y, Zhang Y, Raymont V, et al. A systematic review and meta-analysis of long COVID symptoms. Syst Rev. 2023;12(1):88. doi: 10.1186/s13643-023-02250-0.

Boscolo-Rizzo P, Guida F, Polesel J, Marcuzzo AV, Capriotti V, D’Alessandro A, et al. Sequelae in adults at 12 months after mild-to-moderate coronavirus disease 2019 (COVID-19). Int Forum Allergy Rhinol. 2021;11(12):1685-1688. doi: 10.1002/alr.22832.

Gentilotti E, Górska A, Tami A, Gusinow R, Mirandola M, Rodríguez-Baño J, et al. Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort. EClinicalMedicine. 2023;62:102107. doi: 10.1016/j.eclinm.2023.102107.

Crisafulli E, Clini EM. Measures of dyspnea in pulmonary rehabilitation. Multidiscip Respir Med. 2010;5(3):202. doi: 10.1186/2049-6958-5-3-202.

Fleck MPA, Louzada S, Xavier M, Chachamovich E, Vieira G, Santos L, et al. Aplicação da versão em português do instrumento abreviado de avaliação da qualidade de vida “WHOQOL-bref”. Rev Saude Publica. 2000;34(2):178-183. doi: 10.1590/S0034-89102000000200012.

Adebayo BI, Adejumo OA, Odusanya OO. Health-related quality of life among adults newly diagnosed with pulmonary tuberculosis in Lagos State, Nigeria: a prospective study. Qual Life Res. 2024;33(1):157-168. doi: 10.1007/s11136-023-03506-x.

Nikrah N, Bahari F, Shiri A. Effectiveness of the acceptance and commitment therapy on resilience and quality of life in patients with post-acute COVID-19 syndrome. Appl Nurs Res. 2023;73:151723. doi: 10.1016/j.apnr.2023.151723.

Fernández-de-las-Peñas C, Guijarro C, Plaza-Canteli S, Hernández-Barrera V, Torres-Macho J. Prevalence of post-COVID-19 cough one year after SARS-CoV-2 infection: a multicenter study. Lung. 2021;199(3):249-253. doi: 10.1007/s00408-021-00450-w.

Huang L, Yao Q, Gu X, Wang Q, Ren L, Wang Y, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398(10302):747-758. doi: 10.1016/S0140-6736(21)01755-4.

Lombardo MDM, Foppiani A, Peretti GM, Mangiavini L, Battezzati A, Bertoli S, et al. Long-term coronavirus disease 2019 complications in inpatients and outpatients: a one-year follow-up cohort study. Open Forum Infect Dis. 2021;8(8):ofab384. doi: 10.1093/ofid/ofab384.

Steinbeis F, Thibeault C, Doellinger F, Ring RM, Mittermaier M, Ruwwe-Glösenkamp C, et al. Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: an observational longitudinal study over 12 months. Respir Med. 2022;191:106709. doi: 10.1016/j.rmed.2021.106709.

Maestre-Muñiz MM, Arias Á, Mata-Vázquez E, Martín-Toledano M, López-Larramona G, Ruiz-Chicote AM, et al. Long-term outcomes of patients with coronavirus disease 2019 at one year after hospital discharge. J Clin Med. 2021;10(13):2945. doi: 10.3390/jcm10132945.

Seeßle J, Waterboer T, Hippchen T, Simon J, Kirchner M, Lim A, et al. Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): a prospective cohort study. Clin Infect Dis. 2022;74(7):1191-1198. doi: 10.1093/cid/ciab611.

Grewal JS, Carlsten C, Johnston JC, Shah AS, Wong AW, Ryerson CJ. Post-COVID dyspnea: prevalence, predictors, and outcomes in a longitudinal, prospective cohort. BMC Pulm Med. 2023;23(1):84. doi: 10.1186/s12890-023-02376-w.

D’Cruz RF, Waller MD, Perrin F, Periselneris J, Norton S, Smith LJ, et al. Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia. ERJ Open Res. 2021;7(1):00655-2020. doi: 10.1183/23120541.00655-2020.

Betschart M, Rezek S, Unger I, Ott N, Beyer S, Böni A, et al. One year follow-up of physical performance and quality of life in patients surviving COVID-19: a prospective cohort study. Swiss Med Wkly. 2021;151:w30072. doi: 10.4414/smw.2021.w30072.

Bouteleux B, Henrot P, Ernst R, Grassion L, Raherison-Semjen C, Beaufils F, et al. Respiratory rehabilitation for COVID-19 related persistent dyspnoea: a one-year experience. Respir Med. 2021;189:106648. doi: 10.1016/j.rmed.2021.106648.

Fischer A, Zhang L, Elbéji A, Wilmes P, Oustric P, Staub T, et al. Long COVID symptomatology after 12 months and its impact on quality of life according to initial coronavirus disease 2019 disease severity. Open Forum Infect Dis. 2022;9(8):ofac397. doi: 10.1093/ofid/ofac397.

Verveen A, Wynberg E, van Willigen HDG, Davidovich U, Lok A, Moll van Charante EP, et al. Health-related quality of life among persons with initial mild, moderate, and severe or critical COVID-19 at 1 and 12 months after infection: a prospective cohort study. BMC Med. 2022;20(1):422. doi: 10.1186/s12916-022-02615-7.

Yang T, Yan MZ, Li X, Lau EHY. Sequelae of COVID-19 among previously hospitalized patients up to 1 year after discharge: a systematic review and meta-analysis. Infection. 2022;50(5):1067-1109. doi: 10.1007/s15010-022-01862-3.

Mastrorosa I, Del Duca G, Pinnetti C, Lorenzini P, Vergori A, Brita AC, et al. What is the impact of post-COVID-19 syndrome on health-related quality of life and associated factors: a cross-sectional analysis. Health Qual Life Outcomes. 2023;21(1):28. doi: 10.1186/s12955-023-02107-z.

O’Brien K, Townsend L, Dowds J, Bannan C, Nadarajan P, Kent B, et al. 1-year quality of life and health-outcomes in patients hospitalised with COVID-19: a longitudinal cohort study. Respir Res. 2022;23(1):115. doi: 10.1186/s12931-022-02032-7.

Caamano E, Velasco L, Garcia MV, Asencio JM, Piñeiro P, Hortal J, et al. Prognostic factors for deterioration of quality of life one year after admission to ICU for severe SARS-CoV-2 infection. Qual Life Res. 2024;33(1):123-132. doi: 10.1007/s11136-023-03503-0.

Martínez-Pozas O, Meléndez-Oliva E, Rolando LM, Rico JAQ, Corbellini C, Sánchez Romero EA. The pulmonary rehabilitation effect on long COVID-19 syndrome: a systematic review and meta-analysis. Physiother Res Int. 2024;29(2):e2077. doi: 10.1002/pri.2077.

Zeleke AJ, Moscato S, Miglio R, Chiari L. Length of stay analysis of COVID-19 hospitalizations using a count regression model and quantile regression: a study in Bologna, Italy. Int J Environ Res Public Health. 2022;19(4):2224. doi: 10.3390/ijerph19042224.

Thomas P, Baldwin C, Beach L, Bissett B, Boden I, Cruz SM, et al. Physiotherapy management for COVID-19 in the acute hospital setting and beyond: an update to clinical practice recommendations. J Physiother. 2022;68(1):8-25. doi: 10.1016/j.jphys.2021.12.012.

Wittmer VL, Paro FM, Duarte H, Capellini VK, Barbalho-Moulim MC. Early mobilization and physical exercise in patients with COVID-19: a narrative literature review. Complement Ther Clin Pract. 2021;43:101364. doi: 10.1016/j.ctcp.2021.101364.

Dias LMS, Guimaraes FS, Leite CF, Paro FM, Annoni R, Oliveira ACO, et al. Physiotherapy practice for hospitalized patients with COVID-19. J Bras Pneumol. 2022;48(4):e20220121. doi: 10.36416/1806-3756/e20220121.

Volpe MS, Dias LMS, Leite CF, Annoni R, Paro FM, Oliveira ACO, et al. Chest physiotherapy techniques administered by certified specialists to hospitalized patients with COVID-19 in Brazil: a look towards future practice. Heart Lung. 2023;62:87-94. doi: 10.1016/j.hrtlng.2023.06.005.

Descargas

Publicado

01-12-2025

Número

Sección

Artigos Originais

Cómo citar

1.
Síndrome Postaguda de COVID-19: una cohorte de telemonitoreo de 12 meses para evaluar los síntomas persistentes y la calidad de vida. RBPS [Internet]. 1 de diciembre de 2025 [citado 17 de julio de 2026];27(1):e47684. Disponible en: https://periodicos.ufes.br/rbps/article/view/47684